Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial.
about
A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes.A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects.Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
P2860
Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Safety and efficacy of once-we ...... olled T2D: a randomised trial.
@nl
Safety and efficacy of once-we ...... diabetes: A randomized trial.
@en
type
label
Safety and efficacy of once-we ...... olled T2D: a randomised trial.
@nl
Safety and efficacy of once-we ...... diabetes: A randomized trial.
@en
prefLabel
Safety and efficacy of once-we ...... olled T2D: a randomised trial.
@nl
Safety and efficacy of once-we ...... diabetes: A randomized trial.
@en
P2093
P2860
P356
P1476
Safety and efficacy of once-we ...... diabetes: A randomized trial.
@en
P2093
Arihiro Kiyosue
Atsuko Abiko
Hirotaka Watada
Jeppe Zacho
Tomoyuki Nishida
Yuichiro Yamada
P2860
P304
P356
10.1111/DOM.13218
P50
P577
2018-02-21T00:00:00Z